ARCHIVES

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Alan Davis to Retire From ACS; Five Execs Keep Top Positions

September 10, 1993

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

NIH Cool On OIG, But the Awardees Love it, DeVita Says

October 17, 1986